Study on Gynecological Rare Cancers
Recruiting
Observational Study
Gynecologic Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Female
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- National Cancer Institute, Naples · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective, observational, multicenter study on gynecological rare tumors.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* rare gynecological malignancies
* written informed consent
* patient fit for follow-up
Exclusion criteria
-written informed consent not provided
Contacts
Giorgia Mangili, MD
CONTACT